Jade Biosciences, Inc.

JBIO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$70-$76-$52-$23
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$11$10$8-$7
Other Non-Cash$9$9$5$2
Operating Cash Flow-$71-$57-$39-$27
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$20-$124-$148-$113
Inv. Sales/Matur.$76$136$155$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$56$12$7-$113
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$25$46$0$190
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$25$46$0$190
Forex Effect$0$0$0$0
Net Chg. in Cash$10$1-$32$50
Supplemental Information
Beg. Cash$23$22$54$5
End Cash$34$23$22$54
Free Cash Flow-$71-$57-$39-$28